Browse the evidence

Energy-restricted diets result in modest long-term weight loss (approx. 3% maintained at 5 years) and high relapse rates (>80%) due to compensatory metabolic adaptations including increased hunger hormones (ghrelin), decreased satiety hormones (leptin, GLP-1, PYY), and reduced energy expenditure.

Standard calorie restriction often fails long-term because your body fights back by increasing hunger hormones and lowering metabolism. To succeed, you must manage these biological responses, likely by prioritizing high protein intake to help suppress hunger hormones like ghrelin and preserve metabolic rate, rather than just cutting calories blindly.

Probiotic supplementation for metabolic syndrome yields heterogeneous outcomes: a subset of 'responders' improves triglycerides and diastolic blood pressure, while 'non-responders' experience increased blood glucose and insulin levels.

If you have metabolic syndrome, a probiotic might not help everyone. In this study, some people saw better blood pressure and triglycerides, but others saw worse blood sugar. Your diet matters: responders ate more sugars and specific nutrients like folate and lactose. Before starting a probiotic for metabolic health, consider that it may not work for you, and your current diet might influence whether it helps or harms your metabolic markers.

Dietary intake, specifically higher consumption of sugars, lactose, and folate, distinguishes probiotic responders from non-responders, suggesting diet modulates probiotic efficacy.

Your diet might determine if a probiotic works for you. In this study, people who responded well to the probiotic tended to eat more sugars, lactose, and folate than those who didn't respond. This doesn't mean you should eat more sugar, but it suggests that your current diet interacts with the probiotic. If you're taking a probiotic for metabolic health, your dietary habits are a key part of the equation.

Tirzepatide (5-15 mg once weekly) significantly reduces the risk of composite kidney endpoints (eGFR decline ≥40%, renal death, kidney failure, or new-onset macroalbuminuria) in patients with type 2 diabetes and high cardiovascular risk compared to insulin glargine.

If you have type 2 diabetes and are at high risk for heart or kidney problems, tirzepatide (a once-weekly injection) has been shown to significantly reduce the risk of serious kidney issues compared to insulin glargine. This benefit includes slowing the decline in kidney function and preventing the onset of severe protein in the urine. While there may be an initial, reversible drop in kidney function numbers, this is a sign of reduced stress on the kidneys. Always consult your doctor to see if this treatment is appropriate for your specific health profile.

BCAA supplementation activates anabolic signaling pathways (mTORC1) and improves hormonal profiles (testosterone/cortisol ratio) in the short term, but this does not translate to long-term muscle or strength gains if total protein intake is adequate.

BCAAs do trigger muscle-building signals in your body, but this doesn't mean you will gain muscle or strength. If you are eating enough protein from food, BCAAs add no value. Do not use them to try to 'boost' your muscle growth.

Time-restricted eating (TRE) improves metabolic health markers (insulin sensitivity, glucose control) independent of weight loss when the eating window is aligned with circadian rhythms (early/mid-TRE), whereas late or self-selected windows show little to no benefit.

If you want to try Time-Restricted Eating, start by shifting your eating window to the earlier part of the day (e.g., 8am to 4pm or 10am to 6pm) rather than skipping breakfast or eating late at night. Keep your food choices normal (ad libitum) but ensure you finish eating before 8pm. This alignment with your body's natural circadian rhythms is what drives metabolic improvements, independent of weight loss.

Liraglutide improves insulin sensitivity (measured by HOMA-IR, HOMA2, and Matsuda index) rapidly, within 2 weeks, independent of weight loss.

If you have obesity and prediabetes, liraglutide improves how your body handles insulin within two weeks, even before you lose significant weight. This is a direct drug effect, not just a result of dieting.

Combination therapy using GLP-1 receptor agonists with other hormones (GIP, GCG, or PYY) mimics the beneficial hormonal effects of gastric bypass surgery in non-surgical patients.

New combination drugs that activate multiple gut hormone receptors (like GLP-1, GIP, and Glucagon) are showing strong results in clinical trials for weight loss and blood sugar control, offering a non-surgical alternative to gastric bypass.

Intermittent fasting (IF) regimens improve body composition and cardiometabolic risk factors compared to unrestricted eating, primarily through energy deficit, but do not provide additional benefits over continuous daily caloric restriction when energy balance is matched.

Intermittent fasting works for weight loss and heart health because it helps you eat fewer calories, not because of some magic metabolic switch. If you eat the same amount of calories as someone who eats continuously, you won't get extra benefits from fasting. Use IF if it helps you stick to your calorie goals more easily.

Fasting induces a metabolic switch from glycogenolysis to gluconeogenesis, lipolysis, and ketogenesis, which is considered a main driver of the metabolic health benefits provided by IF.

During fasting, your body switches from burning sugar to burning fat and producing ketones. This metabolic shift is likely why fasting can be healthy, even if it doesn't always lead to more weight loss than just eating less.

B-mode ultrasonography (US) provides valid, reliable, and comparable measurements of vastus lateralis cross-sectional area (VLCSA) changes in response to resistance training-induced hypertrophy and immobilization-induced atrophy when compared to MRI, provided that probe pressure is minimized (<0.2 N) and image stitching techniques are used.

If you are tracking muscle growth or loss using ultrasound, ensure you use a thick layer of gel and apply minimal pressure (just enough for contact, <0.2N) to avoid compressing the muscle. Use image stitching if possible to get a full cross-sectional area view. This method is validated as a reliable alternative to MRI for tracking changes over time in young, healthy men.

Daily ingestion of yogurt containing heat-treated Lactobacillus plantarum OLL2712 (≥5×10^9 cells) for 12 weeks significantly reduces HbA1c levels in prediabetic adults compared to placebo, primarily by preventing the aggravation of chronic inflammation and insulin resistance.

If you are prediabetic, eating 112 grams of yogurt containing heat-treated Lactobacillus plantarum OLL2712 every day for 3 months can help lower your average blood sugar (HbA1c) more than eating regular yogurt. It works by calming chronic inflammation that drives insulin resistance. You do not need to change your diet or exercise routine for this to work, but you should maintain your normal habits.

In prediabetic adults with higher baseline fasting blood glucose (≥107 mg/dL) or insulin resistance (HOMA-IR > 1.6), daily ingestion of heat-treated Lactobacillus plantarum OLL2712 significantly reduces fasting blood glucose and glycoalbumin levels, whereas no significant change occurs in the general population with lower baseline glucose.

If you are prediabetic and have higher fasting blood sugar or insulin resistance, adding this specific yogurt to your daily routine for 3 months may help lower your fasting blood sugar. If your baseline blood sugar is already in the normal range, you might not see a change in fasting levels, though your average blood sugar (HbA1c) may still improve slightly.

Obesity and Type 2 Diabetes are associated with altered secretion patterns of enteroendocrine hormones, specifically decreased GLP-1 and PYY, and increased ghrelin.

In obesity and diabetes, your gut's natural hormone signals are often disrupted, with less 'satiety' hormone (GLP-1) and more 'hunger' hormone (ghrelin). This contributes to the difficulty in managing weight.

The nitrogen balance method used to establish the 0.8 g/kg RDA likely underestimates true protein requirements due to methodological limitations, such as ignoring nonlinearity and metabolic adaptation.

Understand that the old '0.8g/kg' rule was based on a flawed measurement method. It is safer to aim higher, especially if you are active or older.

Fructose consumption, particularly in large amounts or from added sugars, stimulates hepatic de novo lipogenesis and VLDL-triglyceride secretion, increasing intrahepatic fat and cardiovascular risk, whereas glucose and starch have different, often less adverse, metabolic profiles.

Limit added sugars, particularly those high in fructose (like HFCS and sucrose), as they can promote liver fat accumulation and high triglycerides. While whole fruits are healthy due to fiber, be mindful of concentrated fructose sources. Physical activity can mitigate some of these effects by increasing fructose oxidation.

Higher intake of fish and shellfish, dietary fiber, and saturated fatty acids (SFA) is independently associated with a reduced risk of incident atherosclerotic cardiovascular disease (ACVD).

Ensure you are eating at least 300g of fish and shellfish per week and consuming enough dietary fiber (≥2.4g per megajoule of energy). Do not fear saturated fats from whole food sources like dairy, as this study suggests they may be protective when part of a high-quality diet. Focus on the quality of your fats and fibers rather than eliminating them.

Obesity (BMI ≥30 kg/m2) is associated with an increased risk of incident atherosclerotic cardiovascular disease (ACVD).

Maintain a healthy body weight (BMI < 25 kg/m2) to reduce your risk of heart disease and stroke. Obesity is a significant independent risk factor, so managing your weight through diet and physical activity is crucial for long-term cardiovascular health.

Adherence to a Prudent diet (high in fruits, vegetables, lean protein, whole grains) for two weeks significantly increases plasma and urinary levels of 3-methylhistidine and proline betaine, serving as robust biomarkers for healthy eating patterns.

To objectively verify you are eating healthy, focus on a Prudent diet rich in fruits, vegetables, lean proteins, and whole grains. This study shows that just two weeks of this diet significantly alters specific biomarkers (3-methylhistidine and proline betaine) in your blood and urine, providing a clear, objective signal of healthy intake that self-reporting often misses. Ensure your caloric intake matches your needs to maintain weight while making these quality changes.

Adherence to a Prudent diet for two weeks significantly increases urinary levels of imidazole propionate, hydroxypipecolic acid, dihydroxybenzoic acid, enterolactone glucuronide, and plasma levels of ketoleucine and ketovaline.

Eating a Prudent diet rich in fruits, vegetables, and whole grains changes your metabolic profile quickly. Within two weeks, levels of specific compounds like enterolactone glucuronide and ketoleucine rise in your blood and urine. These changes are objective markers of healthy eating, confirming that your diet is supporting metabolic health.

GLP-1 RAs reduce blood pressure and albuminuria in patients with CKD and overweight/obesity, contributing to kidney and cardiovascular protection.

GLP-1 RAs can help lower your blood pressure and reduce protein in your urine (albuminuria), which are important markers for kidney and heart health. This benefit is partly due to weight loss but also direct effects of the medication.

Lifestyle interventions alone are difficult to maintain long-term for weight loss in patients with T2DM and CKD, whereas GLP-1 RAs offer a pharmacological alternative with proven metabolic and organ protection benefits.

While lifestyle changes are important, they are hard to keep up long-term. GLP-1 RAs can help you maintain weight loss and protect your heart and kidneys, making it easier to stick to healthy habits. Talk to your doctor about whether a GLP-1 RA is right for you.

The magnitude of systolic blood pressure reduction with GLP-1 RAs is directly associated with changes in body weight, BMI, and HbA1c, suggesting these metabolic improvements drive the BP benefit.

The blood pressure lowering effect of GLP-1s like semaglutide is largely driven by the weight loss and metabolic improvements (lower A1c/BMI) they cause, rather than a direct effect on blood vessels alone.

Intensive lifestyle intervention (ILI) for weight loss in type 2 diabetes patients with poor glucose control (HbA1c >9%) is associated with an increased risk of cardiovascular disease events, whereas it reduces risk in patients with older onset, severe obesity, or younger onset.

If you have type 2 diabetes and your blood sugar control is consistently poor (high HbA1c), an intensive weight loss program involving strict diet and heavy exercise might actually increase your risk of heart problems. You should discuss your specific glucose control levels with your doctor before starting an intensive lifestyle intervention, as standard advice may not apply to your specific metabolic subgroup.